Peptide Decoding
New?New to peptides?Start here →
Decoding

Myristoyl Pentapeptide-17_Dosage, benefits & legal status

Also known as SymPeptide 226EL, myristoyl pentapeptide 17, lash peptide

Published August 24, 2026 · Updated October 4, 2026

The lash-serum peptide, used where people want to avoid prostaglandins.

Lashes and browsCosmetic peptide (topical)Cosmetic
DoseSerum, per product
FrequencyDaily
RouteOn the skin (topical)
StatusCosmetic ingredient
CycledNot cycled

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Myristoyl Pentapeptide-17?

Plain language first. The technical label stays, but it never stands alone.

Overview

The peptide in most lash serums that avoid prostaglandins. Slower and safer than the prescription drops, and nobody selling it can agree on what it is actually made of.

The technical version

Myristoyl pentapeptide-17, a topical lipopeptide marketed as SymPeptide 226EL, COSING reference 85279, used at roughly 0.001 to 0.1 percent in periocular leave-on products. Claimed activity is upregulation of keratin gene expression in the follicle. Published sequences are inconsistent and no independent single-ingredient trial has been published.

What it's used for

A topical peptide used in lash and brow serums for longer, thicker-looking hair.

02

How does Myristoyl Pentapeptide-17 work?

What it does in the body, and where.

This peptide is the reason many lash serums can advertise results without using a prostaglandin.

  1. 01
    The fatty acid is there to get it through skin
    Myristic acid is a fourteen-carbon fatty acid attached to the front of the peptide. The oily tail helps it cross the outer layer of skin, which a bare peptide struggles to do.
  2. 02
    The claimed action is on keratin
    Keratin is the structural protein a hair is made of. More of it is proposed to mean a thicker, stronger shaft rather than more hairs.
  3. 03
    The real comparison is prostaglandin analogs
    Bimatoprost and its relatives work, and they carry documented risks including permanent iris darkening and orbital fat loss. Peptide serums are slower and much gentler, and the honest trade is a smaller result for a smaller risk.
Where it acts
Eyelashes and brows

Where this compound is thought to act.

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Longer and thicker-looking lashes and brows, applied to the lash lineSupplement or cosmetic
  • Supporting keratin production in the hair shaftEarly research
  • Scalp hair productsnone
  • Paired with myristoyl hexapeptide-16 or biotinoyl tripeptide-1 in multi-peptide serumsnone

The published record

Research index

0

Papers and trials about Myristoyl Pentapeptide-17

Europe PMC was searched on 12 October 2026 and returned nothing.

Counted from Europe PMC indexing, not read by a person.

Myristoyl Pentapeptide-17 vial rendering
Compound field notes

At a glance

Four things to know about Myristoyl Pentapeptide-17

01

Evidence

Cosmetic

02

Category

Skin and cosmetic

03

Common vial

Varies

04

Half-life

Not measured, and not the right question

04

How much, and do you cycle it?

The range, and whether you take breaks.

Serum, per product, daily. Not cycled Community practice

Used daily as part of a routine. The effect depends on continued use and returns to baseline when you stop, so there is nothing to cycle off.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Not measured, and not the right questionNo figure

This is a topical cosmetic ingredient. A blood half-life measures how fast something leaves the bloodstream, and these are not intended to reach it in meaningful amounts. What matters for a topical is how much penetrates the skin and how long it stays in the tissue, which is a different measurement and one that is rarely published.

You can compare this against the whole library to see where it sits.

06

What does it cost?

Typical dose and cost, in plain numbers.

Myristoyl Pentapeptide-17 is not injected

It is taken on the skin (topical). Applied as a topical product at the concentration the manufacturer sets. There is no injected dose.

Cost per month
—
Cost per dose
—
Typical dose
0.1 mcg–10 mcg / formulationCommunity practice
07

How do you store it?

Before mixing, and after.

Room temperature, out of light. Cap it tight after each use.

Myristoyl Pentapeptide-17 ships as a cream, gel, or serum. Keep it at room temperature away from sun and heat unless the label says otherwise. Refrigerating an emulsion can split the texture. Watch for color, smell, or separation changes and stop using it if any appear.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Solubility, computed: 100% charged residues, 40% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • A known allergy to this ingredient or to others in the same product
  • Broken, cracked, or actively irritated skin
  • Use inside the eye or on the waterline, since lash products are meant for the skin above the lash line only
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • A rash that spreads beyond where you applied it
  • Swelling of the face, lips, or eyelids, or any trouble breathing
  • Burning that does not settle after rinsing it off
  • Redness, itching or swelling of the eyelid
  • Any change in vision
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Reactions are not commonly reported, though no published testing has looked for them. Irritation from a product containing it may come from anything else in the formula.

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Myristoyl Pentapeptide-17 approved?

And where the numbers on this page come from.

Not as a medicine. Myristoyl Pentapeptide-17 is sold without a prescription as a cosmetic ingredient, which is a different thing from being approved as a drug.

  • Approval status
    CosmeticSold without a prescription as an ingredient in cosmetics, such as skincare and hair products. The FDA does not approve cosmetics before they are sold, and being easy to buy says nothing about whether it works.
  • Route
    On the skin (topical)
  • Checked
    24 August 2026
  • Dose
    From the concentration range manufacturers formulate at. This is a product strength, not a dose set by a regulator or a trial.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

Regulated as a cosmetic ingredient, not a drug. Cosmetic ingredients are not reviewed for effectiveness before sale in the US, so a product may legally claim an appearance benefit without a trial behind it.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence